This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Respiratory Professional Care

If you would like more information on the respiratory system, please refer to the NHS website.

Visit the NHS website?

Legal Notice

RESPIRATORY PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR RESPIRATORY PROFESSIONAL CARE CAN BE FOUND HERE.

Co-Located Events

Exhibitor Products

Subpage Hero

     

08 Sep 2024

Aerogen Ultra

Aerogen Stand: RC40

Aerogen Ultra

  • Oxygen port enables optional delivery of oxygen2
  • An ergonomic valved mouthpiece controls the flow of air through the chamber to facilitate aerosol drug delivery2
  • Innovative chamber design provides an aerosol reservoir intended for optimal drug delivery2
  • Extended mouthpiece to easily add bacterial or viral filter2

The Aerogen Ultra with an extended mouthpiece is only available in selected regions, refer to the relevant instruction manual for your region to determine availability 

Effectiveness

Aerogen Ultra facilitates effective medication delivery during self-ventilation3–6

In studies, bronchodilator administration via the Aerogen Ultra was associated with:

  • 6x more medication delivered to the lungs during self-ventilation versus a jet nebuliser3†
  • Significantly less medication left in the cup versus other nebulisers3,‡4

Study performed in healthy subjects; between-group difference: 34.1% vs 5.2%; p<0.001
In-vitro/ex vivo models

 

Patient care

Aerogen Ultra improves patient care in response to aerosolised medication5,6

In studies, when compared with jet nebulisers, bronchodilator administration via Aerogen Ultra was associated with:

In children with a moderate-to-severe asthma exacerbation:

  • Significantly fewer treatments and significantly less time required to achieve symptom control†5

Across patients in an emergency department:

  • 32% relative reduction in hospital admission rates6
  • 85% of patients achieving symptom control with one 2.5 mg salbutamol dose6
  • 37-minute reduction in emergency department median length of stay6

Defined as achieving a mild asthma score following an asthma exacerbation

 

Workflow

Aerogen simplifies the workflow

  • Virtually silent delivery,2 keeping a calm environment for your patients
  • No added flow2
  • Aerogen is intended for the aerosolisation of any  physician-prescribed medications for inhalation, which are approved for use with a general purpose nebuliser2
  • One system used throughout a patient's respiratory journey (IMV, NIV, HF, SV),supporting continuity of care
Loading

Newsletter Sign Up